Phase I Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies.
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2012
At a glance
- Drugs MABp1 (Primary)
- Indications Acute lymphoblastic leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Haematological malignancies
- Focus Adverse reactions; Pharmacokinetics
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2012 Planned End Date changed from 1 Aug 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.